Business · retail

FINO Cannabis Opens First Florida Dispensary in Market Expansion Push

The multistate operator launches its inaugural Florida retail location as competition intensifies in the state's medical cannabis market.

By Mei Chen, Cannabis Tech ReporterPublished June 23, 2026Updated June 23, 20264 min read
Front view of a Ganja Station store in Pattaya, showcasing cannabis-themed signage and street vendors.

Front view of a Ganja Station store in Pattaya, showcasing cannabis-themed signage and street vendors.

FINO Cannabis opened its first Florida dispensary June 23, 2026, entering one of the nation's largest medical cannabis markets with over 850,000 registered patients and $2.1 billion in annual sales.

Florida Market Entry Marks Geographic Expansion

FINO Cannabis launched its first Florida retail location June 23, 2026, entering a state medical cannabis market that generated $2.1 billion in sales during 2025. The opening represents the company's first physical footprint in Florida, where vertical integration requirements mandate that dispensary operators also hold cultivation and processing licenses.

Florida's Office of Medical Marijuana Use currently licenses 25 vertically integrated operators, each permitted to open an unlimited number of dispensaries statewide. FINO's entry follows a pattern of out-of-state MSOs establishing Florida operations through license acquisitions or new application rounds.

Competitive Landscape in Florida Cannabis Retail

FINO enters a market dominated by Trulieve, which operates over 120 Florida dispensaries and controls approximately 45% of state market share. Other major competitors include:

  • Curaleaf: 68 Florida locations
  • Verano (MÜV): 54 locations
  • Surterra Wellness: 48 locations
  • Ayr Wellness (Liberty Health Sciences): 32 locations

The state's vertically integrated license structure creates high barriers to entry while allowing operators to control margins across cultivation, processing, and retail.

Operational Infrastructure Requirements

Florida's vertical integration mandate requires FINO to operate cultivation and processing facilities in addition to retail dispensaries. The company must maintain seed-to-sale tracking through the state's Metrc system, with real-time inventory reporting to the Department of Health.

Medical marijuana treatment centers in Florida face strict operational requirements: product testing through state-licensed labs, physician certification verification for all patient purchases, mandatory security systems including 24/7 video surveillance retained for 45 days.

Technology Stack for Florida Compliance

Dispensaries in Florida typically deploy integrated POS systems that sync with Metrc for real-time compliance reporting. Common vendor configurations include:

  • Dutchie or Jane for e-commerce and online ordering
  • Flowhub, Cova, or Treez for in-store POS with Metrc API integration
  • Alleaves or BioTrack for seed-to-sale tracking across cultivation and manufacturing

Payment rails remain cash-heavy due to federal banking restrictions. Some Florida operators have secured state-chartered bank relationships for limited debit processing, though these remain the exception.

Patient Registration and Purchase Limits

Florida's medical marijuana program restricts purchases to patients with active physician certifications and state-issued medical marijuana use registry cards. As of June 2026, the state had 857,000 registered patients, up 6% year-over-year.

Purchase limits vary by product form. Smokable flower: 2.5 ounces per 35-day rolling period. Concentrates and edibles: milligram-based limits set by physician recommendation routes. Dispensaries must verify patient eligibility and remaining allotment before completing transactions.

Pricing Dynamics and Market Positioning

Average Florida cannabis prices have declined 18% since 2024 due to increased competition and cultivation capacity expansion. Eighth-ounce flower pricing now ranges from $25 to $55 depending on brand tier and THC content. Concentrate pricing spans $40 to $80 per gram.

FINO hasn't disclosed its pricing strategy or product assortment for the Florida market. The company will need to balance margin preservation against aggressive promotional tactics used by dominant players like Trulieve, which regularly offers 25-40% discounts to drive volume.

Adult-Use Ballot Initiative Looms Over Market

Florida voters will decide on adult-use legalization in November 2026 through a constitutional amendment requiring 60% approval. If passed, the measure would open recreational sales to all adults 21+ while maintaining the existing vertically integrated license structure.

Current medical operators would gain first-mover advantage in adult-use sales, but the market would face immediate demand surge. Analysts project Florida adult-use sales could reach $4.5 billion annually by 2028 if the ballot measure passes. For the full regulatory picture shaping this expansion, see the CannIntel topic hub on Florida Cannabis Market.

We'll be watching FINO's cultivation and processing facility announcements in coming months, and whether the company signals additional Florida dispensary openings before the November ballot decision.

Sources

FINO CannabisFloridadispensary openingmedical marijuanaMSO expansionTrulieve
The CannIntel Daily

The cannabis newsletter you forward to your team.

Federal policy, market data, grower alerts, and the one story that matters today. Sent every weekday at 7am. Free.

No spam. Unsubscribe with one click. 21+ only.

Related from Business

More from the newsroom